This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Zika Virus Testing Market

Market Insights on Zika Virus Testing covering sales outlook, demand forecast & up-to-date key trends

Zika Virus Testing Market by Test Type (Rapid IgG/IgM Test, ELISA Test), End-User (Hospitals & Clinics, Private Commercial Laboratories, Government/Publicly Funded Programs) & Region - Forecast to 2021-2031

About the Report

Diagnostic testing has entered a new phase with the advent of constant viral pandemic and epidemic outbreaks, prompting clinicians and healthcare stakeholders to introduce highly sophisticated and precise testing solutions to ward of such threats. The ever exploding frequencies of viral epidemics has put the global healthcare fraternity at the cusp of significant technological revolutions, which has boded well for the zika virus testing market.

Healthcare providers are increasing leaning towards enzyme-linked immunosorbent (ELISA) and IgG/IgA testing mechanisms, attributed to their high throughput rates and enhanced accuracy degree. Prominent zika virus testing players are also looking to leverage major institutional level collaborations with government agencies as well as private laboratories to accelerate their research and development prospects.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for zika virus treatment. The report tracks the global sales of zika virus treatment in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare industry in general, and zika virus treatment in particular.

Customize this Report

Let us know your requirement to get
100% FREE customization

How do the Historical Projections and Future Outlook Compare?

According to Future Market Insights, the zika virus testing market experienced moderate growth, registering a CAGR of over 2% until 2020. The market surpassed US$ 4 billion in value as government initiatives to contain the virus’s spread resulted in massive awareness campaigns which accelerated the frequency of infection diagnostics and testing.

As the intensity of the epidemic has waned, the incidence of testing has significantly dwindled. However, government and institutional level efforts are unceasing in terms of discovering possible new breakthroughs in the future. Furthermore, the existing COVID-19 pandemic has prompted individuals to screen for any possibility of viral strain presence as a precautionary measure, elevating growth prospects.

How are Increasing Epidemic Outbreaks contributing to Market Growth?

Since the dawn of the 21st century, the global healthcare community has been wrestling with countless epidemic outbreaks, which has significantly stretched existing infrastructure capabilities. Amongst all the pandemics and epidemics faced today, viral infections have acquired the topmost position, with diseases such as the Severe Acute Respiratory Syndrome (SARS), the Middle Eastern Respiratory Syndrome (MERS), Chikungunya, Swine Flu, Zika Virus and the COVID-19 pandemic being some examples.

Fortunately, numerous technological advancements has enabled the global healthcare industry to develop effective virology diagnostic and treatment procedures, leading to the introduction of highly advanced testing mechanisms. Multiple approaches, including viral culture, antigen detection, nucleic acid detection and serology. Viral isolation and a number of methods of detection of viral antigens, nucleic acids, and antibodies are at the core repertoire of techniques used for laboratory diagnosis of numerous viral infections.

All the aforementioned approaches have been extensively deployed to diagnose and contain the zika virus epidemic with largely successful results. Prominent laboratories are investing their funds in developing immunoglobulin testing and enzyme-linked immunosorbent assay (ELISA). Players such as LabCorp are at the forefront of the zika virus testing market, offering the Aptima® Zika Virus Assay and the ZIKV DetectTM IgM Capture ELISA which were authorized for emergency use initially. Such developments are further widening growth prospects in the future.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is Demand for Zika Virus Testing High for Pregnant Women?

Documented findings have established that the zika virus has a high possibility of being passed on from a pregnant woman to her fetus. Infection during pregnancy leads to microcephaly and other severe fetal brain defects. Additionally, it may result in neurodevelopmental abnormalities such as hearing and visual impairment, limited locomotion, seizures and other abnormalities.

Therefore, it has become imperative for women to undergo periodic screening for possible presence of the virus in their bloodstream. According to the World Health Organization, zika virus infection is also a trigger for Guillain-Barre syndrome, neuropathy and myelitis, particularly in adults and older children. Hence, it is highly advisable for women residing within zika intensive areas to undergo laboratory testing and other clinical care.

At the same time, clinicians are advocating a slew of preventive measures owing to the dearth of any vaccine or drug to treat the virus. As it is a vector borne disease, mostly through mosquitos, personal protection measures such as wearing light-colored clothing that covers as much of the body as possible. Furthermore, using physical barriers such as window screens and closed doors and windows and applying insect repellants are considered the best alternatives.

Key Challenges faced by the Zika Virus Testing Providers

A major factor impeding revenue growth of the zika virus testing market is the inefficiency of these tests in delivering results. While ELISA tests are said to provide relatively accurate results compared to IgG/IgM testing, yet companies are unable to deliver products owing to cross reactivity with other widely circulating virus strands such as Flavivirus, Dengue, Chikungunya and Japanese Encephalitis.

Furthermore, the outreach of zika virus testing is restricted to tropical regions, as these are the primary infection hotspots, thus restricting their growth scope. Fortunately, countries across the temperate regions are increasing uptake of various serological tests amid growing concerns of the epidemic’s spread by virtue of people frequenting tropical regions for tourism.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

What Prospects are in Store for the US Zika Virus Testing Market?

Presently, as of 2021, there have been no documented instances of local zika virus transmission across the US. However, overseas territories have registered 7 active cases through presumed local mosquito-borne transmission. This number represents an impressive reduction as compared to 2019 levels wherein 28 active cases were reported, 27 in travelers returning from affected areas and 1 from laboratory exposure.

This reduction in cases is majorly credited to numerous regulatory approaches to facilitate active viral case load testing since the past few years. For instance, in May 2019, the Food & Drug Administration authorized marketing of the ZIKV Detect 2.0 IgM Capture ELISA to detect Zika virus Immunoglobulin (IgM) antibodies in human blood. This was the first diagnostic test permitted by the FDA to be commercially available.

Likewise, in July 2019, FDA cleared the ADVIA Center Zika test, making it the second major IgM antibody test to be commercially available. Earlier, this test was only permitted for emergency use by decree of the FDA’s emergency use authorization directive. Two other tests- the LIASION XL Zika Capture IgM Assay II and DPP Zika IgM Assay System were eventually granted approval subsequently. Attributed to these approvals, scope for the US market is increasing manifold.

Is Brazil Expected to Generate Revenue Streams for Prominent Players?

Prominent zika virus testing players are expected to find credible opportunities across the Brazilian market, given the fact it was the epicenter of the initial epidemic outbreak. The outbreak was first documented by the discovery of fetal microcephaly across northeastern Brazil in 2015. In view of the harmful consequence of microcephaly, in November 2015 the Ministry of Health declared a Public Health Emergency of National Concern.

To combat this menace, the Brazilian government introduced a massive nationwide operation to eliminate potential mosquito breeding sites and to educate the public about its role in combating spread of the disease. In the initial stages, health worker or members of the armed forces visited over 20 million homes, representing almost 30% of all the country’s private residences. Such unceasing efforts led to a nationwide improvement in the eradication efforts of the virus.

Presently, Brazilian authorities have taken crucial measures in a transparent and timely manner in line with the International Health Regulations, a legal instrument which is binding for all World Health Organization member states, for which the country has invested in purchasing essential materials such as laboratory reagents, insecticides and diagnostic kits. Moreover, the WHO is also assisting Brazil in strengthening integrated management of disease-carrying organisms in public health, including upscaling use of larvicides to inhibit breeding of the Aedes mosquitos, the main vectors responsible for the virus’ transmission.

How did Puerto Rico Generate High Ground for Zika Virus Testing?

According to the Centers for Disease Control and Prevention (CDC), zika virus is a major factor for microcephaly and other severe birth defects in babies born to women infected with the virus. Women living in Puerto Rico are especially at high risk of zika virus exposure due to local mosquito-borne transmission.

Beginning in 2016, healthcare providers in Puerto Rico were under administrative orders to provide counseling on zika virus risk-reduction strategies, assess patients for possible zika virus exposure during prenatal care visits and conduct prenatal testing for Zika virus. Additionally, the Puerto Rico Department of Health (PRDH) and the CDC worked together to conduct a population-based survey of women who gave birth to a live infant from August to December 2016.

The Pregnancy Risk Assessment Monitoring System - Zika Postpartum Emergency Response (PRAMS-ZPER) survey asked mothers about their use of recommended measures to prevent zika virus infection and their interactions with healthcare providers during their pregnancy. Most respondents replied that they received prenatal care in the 1st trimester (91%), while more than seven out of ten considered their healthcare provider to be the best source of information about the virus. Hence, regular diagnostic tests are administered to them to periodically check for any infections.

What are the Major Zika Virus Testing Guidelines in the UK?

According to Public Health England (PHE), testing for zika virus is available only through the Rare and Imported Pathogens Laboratory (RIPL) at PHE Porton. RIPL provides medical and laboratory specialist services to the National Health Service and other healthcare providers, covering advice and diagnosis of a wide range of unusual bacterial and viral infections, including zika virus infection.

Zika Virus Testing Market Download Report Brochure

As per UK law, zika virus infection is not a notifiable disease. Therefore, there is no statutory requirement to test for this infection if the result are expected to have a negligible impact on clinical management. Presently, testing services are inaccessible for asymptomatic individuals, including pregnant women, male travelers and couples who are attempting to conceive. Couples planning conception should be strongly advised to follow PHE guidance and delay conception for 3 months after return from a country or area with risk for zika, rather than pay for private zika tests that may not be fully validated for testing people who don’t have symptoms.   

With regard to investigating patients with previously suspected infection cases, clinicians can undertake testing for any patient who has had a rash illness or other symptoms suggestive of zika virus infection within 2 weeks of leaving any country suspected of having an outbreak. In such a case, patients have to submit serum or urine samples with an appropriate request form. Additionally, semen samples may also be tested in case of conceiving parents.

Category-wise Insights

Why are ELISA based Tests Most Preferred?

By test type, ELISA-based zika virus testing is the most preferred, surpassing US$ 4 billion until 2020. ELISA tests are highly relied upon due to its high specificity and sensitivity. Additionally, they offer greater accuracy compared to other techniques such as radioimmunoassay (RIA) tests. Moreover, it does not require radioisotopes or costly radiation counters.

Simultaneously, demand for IgG/IgM testing is anticipated to remain equally strong, reaching US$ 26 million in valuation as of 2020. These tests have exhibited promising results due to minimal sample requirement and complications associated with their usage. These tests help in simultaneous detection and differentiation of the zika virus in human serum and plasma.

Demand for Testing Kits to Remain High across Commercial Laboratories?

By end-user, zika virus testing is likely to be extensively carried out by private commercial laboratories. Private laboratories often have more resources at their disposal, including finances for initiating new clinical trials, affordability of sophisticated lab equipment, and enhanced specimen storage capacities among other benefits. Prominent private commercial laboratories offering zika virus testing include Labcorp and ARUP Laboratories among others.

At the same time, government/publicly funded testing programs have experienced a significant incline. For example, in 2016, the US Congress allocated US$ 1.1 billion in supplemental funding to combat the zika virus to the Department of Health and Human Services (HHS), out of which US$ 394 million was allocated to CDC, US$ 152 million to NIH and US$ 387 million towards the public health and emergency fund.

Competitive Landscape

Prominent zika virus testing players are majorly emphasizing on incorporating advanced testing approaches to provide faster turn-around times and quicker results. This helps clinicians suggest the appropriate treatment approach to infected patients. They also rely on strategic collaborations with various institutions and companies to widen their market presence.

EUROIMMUN US is a prominent zika virus test provider, offering the anti-zika virus ELISA and indirect immunofluorescence test (IFA) formats which allows for detection of specific antibodies (IgM and IgG) in the blood of those who may be infected. In 2017, the company entered an optional agreement with Roche Diagnostics in which the latter gained access to intellectual property in zika virus immunodiagnostics assigned to EUROIMMUN.

Similarly, Creative Diagnostics offers the Recombinant Zika Virus Envelope protein test which contains Histidine tags. The protein reacts with both IgG and IgM to provide the desired result. Its purity score ranks above 85%, available in 1 mg vials. It also offers the Recombinant Zika Virus NS1 protein test.

Recently, in April 2021, Luminex Corporation has signed and acquisition agreement with DiaSorin S.p.A. wherein the latter has agreed to acquire the former. Luminex believes that this transaction will generate significant opportunities for both companies to gain access to broader assay portfolios, enhanced research tools and expanded support services. This collaboration will also drive new partnerships in the biopharmaceutical, academic and clinical spaces.

As per FMI’s analysis, the following players operate within the global zika virus testing market:

  • EUROIMMUN US Inc.
  • Creative Diagnostics
  • Quest Diagnostics
  • Artron Laboratories Inc.
  • RapiGEN Inc.
  • GenBody Inc.
  • JAJ International Inc.
  • LumiQuick Diagnostics Inc.
  • Biocan Diagnostics Inc.
  • NECTAR LIFESCIENCES LTD.
  • Luminex Corporation
  • ARUP Laboratories
  • Abbott Molecular Inc.
  • Hologic
  • Vela Diagnostics

*This list is indicative - full details about prominent zika virus testing manufacturers is available upon request

Zika Virus Testing Market - Report Scope

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

US$ Mn for Value & ‘000 Units for Volume

Key Regions Covered

North America & Europe, Latin America, Central America, Caribbean, South East Asia and Rest of the World

Key Countries Covered

US, Brazil, Mexico, Colombia, Germany, Italy, France, UK, Spain, Costa Rica, Nicaragua, Guatemala, Puerto Rico, Thailand, Vietnam, Singapore, North Africa and South Africa

Key Segments Covered

Test Type and End-User

Key Companies Profiled

  • EUROIMMUN US Inc.
  • Creative Diagnostics
  • Quest Diagnostics
  • Artron Laboratories Inc.
  • RapiGEN Inc.
  • GenBody Inc.
  • JAJ International Inc.
  • LumiQuick Diagnostics Inc.
  • Biocan Diagnostics Inc.
  • NECTAR LIFESCIENCES LTD.
  • Luminex Corporation
  • ARUP Laboratories
  • Abbott Molecular Inc.
  • Hologic
  • Vela Diagnostics

Report Coverage

Market Introduction, Market Viewpoint, Market Background, Key Macroeconomic Assumptions, Global Economic Outlook, Key Inclusions, Market Analysis & Forecast, Segmental Analysis, Regional Profiling, Forecast Assumptions, Market Structure Analysis and Competition Analysis

Customization & Pricing

Available upon Request

Key Segments Covered

Test Type

  • Rapid IgG/IgM Test
  • ELISA Test

End-User

  • Hospitals & Clinics
  • Private Commercial Laboratories
  • Government/Publicly Funded Programs

Region

  • North America & Europe (US, UK, Germany, Spain, France, Italy and Rest of Europe)
  • Latin America (Brazil, Mexico, Colombia  and Rest of LATAM)
  • Central America (Costa Rica, Nicaragua, Guatemala and Rest of Central America)
  • Caribbean (Puerto Rico and Rest of the Caribbean)
  • South East Asia (Thailand, Singapore, Vietnam and Rest of South East Asia)
  • Rest of the World (North Africa and South Africa)

Frequently Asked Questions

The global zika virus testing market is set to register credible gains through 2021 and beyond, registering a multi-billion dollar valuation amid extensive research and development to incorporate highly advanced diagnostic approaches which will help in timely detection and diagnosis of the virus

As per FMI’s report, bulk of all zika virus testing is expected to occur across the tropical regions of the world, such as the Asian sub-continent, Caribbean and Central America respectively

ELISA based zika virus testing treatment will likely remain the most preferred approach in forthcoming years due to its immense promises in terms of higher accuracy and efficacy

EUROIMMUN US Inc., Creative Diagnostics, Quest Diagnostics, Artron Laboratories Inc., RapiGEN Inc., GenBody Inc., JAJ International Inc., LumiQuick Diagnostics Inc., Biocan Diagnostics Inc., NECTAR LIFESCIENCES LTD., Luminex Corporation, ARUP Laboratories, Abbott Molecular Inc., Hologic and Vela Diagnostics are some prominent regenerative medicine players profiled by FMI’s report

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Zika Virus Testing Market View Point

    3.1. Tracking the market scenario, with key inferences drawn from historical data, current trends, and future prospects

    3.2. Macro-Economic Factors

    3.3. Opportunity Analysis

4. Market Background

    4.1. Technology Evolution

    4.2. List of Growth Hacking Manufacturers

    4.3. Value Chain

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity Analysis

    4.5. Reimbursement Landscape

    4.6. Regulatory Scenario

5. Macroeconomic Assumptions

6. Global Economic Outlook

    6.1. Gross Domestic Product by Region & Country, 2021 – 2031

    6.2. Disease Outlook

7. Key Inclusions

    7.1. Key Distributor List

    7.2. Key Mergers & Acquisitions

8. Global Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031 By Region

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2016 – 2020

        8.2.1. North America

        8.2.2. Latin America

        8.2.3. Central America

        8.2.4. Caribbean

        8.2.5. South East Asia

        8.2.6. Rest of the World

    8.3. Market Size (US$ Mn) Forecast By Region, 2021 – 2031

    8.4. Market Attractiveness Analysis By Region

9. Global Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By End User

    9.1. Introduction/Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By End User, 2016 – 2020

        9.2.1. Hospital Pharmacies

        9.2.2. Retail Pharmacies and Drug Stores

        9.2.3. Online Sales

        9.2.4. Other

    9.3. Market Size (US$ Mn) and Volume Forecast By End User, 2021 – 2031

    9.4. Market Attractiveness Analysis By End User

10. Global Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    10.1. Market Value Share Analysis, By All Segment

    10.2. Y-o-Y Growth Analysis, By All Segment

    10.3. Absolute $ Opportunity

11. North America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    11.1. Introduction

    11.2. Key Takeaways

    11.3. Regional Market Trends

    11.4. U.S. Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        11.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            11.4.1.1. Hospitals & Clinics

            11.4.1.2. Private Commercial Laboratories

            11.4.1.3. Government/ Publicly Funded Programs

        11.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        11.4.3. Pricing Analysis

        11.4.4. Government Initiatives and Spending Scenario

        11.4.5. Key Competition Mapping

    11.5. Market Attractiveness Analysis

        11.5.1. By End User

    11.6. Key Market Participants – Intensity Mapping

12. Europe Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    12.1. Introduction

    12.2. Key Takeaways

    12.3. Regional Market Trends

    12.4. Germany Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        12.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            12.4.1.1. Hospitals & Clinics

            12.4.1.2. Private Commercial Laboratories

            12.4.1.3. Government/ Publicly Funded Programs

        12.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        12.4.3. Pricing Analysis

        12.4.4. Government Initiatives and Spending Scenario

        12.4.5. Key Competition Mapping

    12.5. United Kingdom Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        12.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            12.5.1.1. Hospitals & Clinics

            12.5.1.2. Private Commercial Laboratories

            12.5.1.3. Government/ Publicly Funded Programs

        12.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        12.5.3. Pricing Analysis

        12.5.4. Government Initiatives and Spending Scenario

        12.5.5. Key Competition Mapping

    12.6. France Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        12.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            12.6.1.1. Hospitals & Clinics

            12.6.1.2. Private Commercial Laboratories

            12.6.1.3. Government/ Publicly Funded Programs

        12.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        12.6.3. Pricing Analysis

        12.6.4. Government Initiatives and Spending Scenario

        12.6.5. Key Competition Mapping

    12.7. Italy Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        12.7.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            12.7.1.1. Hospitals & Clinics

            12.7.1.1. Private Commercial Laboratories

            12.7.1.1. Government/ Publicly Funded Programs

        12.7.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        12.7.3. Pricing Analysis

        12.7.4. Government Initiatives and Spending Scenario

        12.7.5. Key Competition Mapping

    12.8. Spain Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        12.8.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            12.8.1.1. Hospitals & Clinics

            12.8.1.2. Private Commercial Laboratories

            12.8.1.3. Government/ Publicly Funded Programs

        12.8.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        12.8.3. Pricing Analysis

        12.8.4. Government Initiatives and Spending Scenario

        12.8.5. Key Competition Mapping

    12.9. Market Attractiveness Analysis

        12.9.1. By Country

        12.9.2. By End User

    12.10. Key Market Participants – Intensity Mapping

13. Caribbean Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    13.1. Introduction

    13.2. Key Takeaways

    13.3. Regional Market Trends

    13.4. Puerto Rico Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        13.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            13.4.1.1. Hospitals & Clinics

            13.4.1.2. Private Commercial Laboratories

            13.4.1.3. Government/ Publicly Funded Programs

        13.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        13.4.3. Pricing Analysis

        13.4.4. Government Initiatives and Spending Scenario

14. Latin America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    14.1. Introduction

    14.2. Key Takeaways

    14.3. Regional Market Trends

    14.4. Brazil Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        14.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            14.4.1.1. Hospitals & Clinics

            14.4.1.2. Private Commercial Laboratories

            14.4.1.3. Government/ Publicly Funded Programs

        14.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        14.4.3. Pricing Analysis

        14.4.4. Government Initiatives and Spending Scenario

    14.5. Mexico Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        14.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            14.5.1.1. Hospitals & Clinics

            14.5.1.2. Private Commercial Laboratories

            14.5.1.3. Government/ Publicly Funded Programs

        14.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        14.5.3. Pricing Analysis

        14.5.4. Government Initiatives and Spending Scenario

    14.6. Columbia Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        14.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            14.6.1.1. Hospitals & Clinics

            14.6.1.2. Private Commercial Laboratories

            14.6.1.3. Government/ Publicly Funded Programs

        14.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        14.6.3. Pricing Analysis

        14.6.4. Government Initiatives and Spending Scenario

    14.7. Market Attractiveness Analysis

        14.7.1. By Country

        14.7.2. By End User

    14.8. Key Market Participants – Intensity Mapping

15. Central America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    15.1. Introduction

    15.2. Key Takeaways

    15.3. Regional Market Trends

    15.4. Central America Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        15.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            15.4.1.1. Hospitals & Clinics

            15.4.1.2. Private Commercial Laboratories

            15.4.1.3. Government/ Publicly Funded Programs

        15.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        15.4.3. Pricing Analysis

        15.4.4. Government Initiatives and Spending Scenario

    15.5. Key Competition Mapping

    15.6. Market Attractiveness Analysis

        15.6.1. By End User

    15.7. Key Market Participants – Intensity Mapping

16. South-East Asia Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    16.1. Introduction

    16.2. Key Takeaways

    16.3. Regional Market Trends

    16.4. Indonesia Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        16.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            16.4.1.1. Hospitals & Clinics

            16.4.1.2. Private Commercial Laboratories

            16.4.1.3. Government/ Publicly Funded Programs

        16.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        16.4.3. Pricing Analysis

        16.4.4. Government Initiatives and Spending Scenario

    16.5. Thailand Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        16.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            16.5.1.1. Hospitals & Clinics

            16.5.1.2. Private Commercial Laboratories

            16.5.1.3. Government/ Publicly Funded Programs

        16.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        16.5.3. Pricing Analysis

        16.5.4. Government Initiatives and Spending Scenario

    16.6. Singapore Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        16.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            16.6.1.1. Hospitals & Clinics

            16.6.1.2. Private Commercial Laboratories

            16.6.1.3. Government/ Publicly Funded Programs

        16.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        16.6.3. Pricing Analysis

        13.6.4. Government Initiatives and Spending Scenario

    16.7. Vietnam Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        16.7.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            16.7.1.1. Hospitals & Clinics

            16.7.1.2. Private Commercial Laboratories

            16.7.1.3. Government/ Publicly Funded Programs

        16.7.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        16.7.3. Pricing Analysis

        16.7.4. Government Initiatives and Spending Scenario

    16.8. Key Competition Mapping

    16.9. Market Attractiveness Analysis

        16.9.1. By Country

        16.9.2. By End User

    16.10. Key Market Participants – Intensity Mapping

17. Rest of the World Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    17.1. Introduction

    17.2. Key Takeaways

    17.3. Regional Market Trends

    17.4. North Africa Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        17.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            17.4.1.1. Hospitals & Clinics

            17.4.1.2. Private Commercial Laboratories

            17.4.1.3. Government/ Publicly Funded Programs

        17.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        17.4.3. Pricing Analysis

        17.4.4. Government Initiatives and Spending Scenario

    17.5. South Africa Zika Virus Testing Market Analysis 2016 – 2020 and Forecast 2021 – 2031

        17.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2016 – 2020

            17.5.1.1. Hospitals & Clinics

            17.5.1.2. Private Commercial Laboratories

            17.5.1.3. Government/ Publicly Funded Programs

        17.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2021 – 2031

        17.5.3. Pricing Analysis

        17.5.4. Government Initiatives and Spending Scenario

    17.6. Key Competition Mapping

    17.7. Market Attractiveness Analysis

        17.7.1. By Country

        17.7.2. By End User

    17.8. Key Market Participants – Intensity Mapping

18. Forecast Factors: Relevance and Impact

19. Forecast Assumptions

20. Market Structure Analysis

    20.1. Market Structure by Tier of Companies

   20.2. Market Share Analysis (2016) for Top 10 Players, By Region

   20.3. Production Capacity Analysis, By Key Players

   20.4. Pricing Analysis By Key Players, By Region

21. Competition Analysis

   21.1. Company Deep Dive Profile of some of the key market players, with specific focus on business and Zika Virus Testing Market

   21.2. Competition Dashboard

   21.3. Competition Benchmarking

   21.4. Profitability and Gross Margin Analysis By Competition

   21.5. Company Deep Dive

       21.5.1. EUROIMMUN US, Inc.

           21.5.1.1. Overview

            21.5.1.2. Product and Application Portfolio

            21.5.1.3. Production Footprint

            21.5.1.4. Sales Footprint

            21.5.1.5. Channel Footprint

            21.5.1.6. Strategy

                21.5.1.6.1. Marketing Strategy

                21.5.1.6.2. Product Strategy

                21.5.1.6.3. Channel Strategy

        21.5.2. Creative Diagnostics

            21.5.2.1. Overview

            21.5.2.2. Product and Application Portfolio

            21.5.2.3. Production Footprint

            21.5.2.4. Sales Footprint

            21.5.2.5. Channel Footprint

            21.5.2.6. Strategy

                21.5.2.6.1. Marketing Strategy

                21.5.2.6.2. Product Strategy

                21.5.2.6.3. Channel Strategy

       21.5.3. Quest Diagnostics

           21.5.3.1. Overview

           21.5.3.2. Product and Application Portfolio

           21.5.3.3. Production Footprint

           21.5.3.4. Sales Footprint

           21.5.3.5. Channel Footprint

           21.5.3.6. Strategy

               21.5.3.6.1. Marketing Strategy

               21.5.3.6.2. Product Strategy

               21.5.3.6.3. Channel Strategy

       21.5.4. Artron Laboratories Inc.

           21.5.4.1. Overview

           21.5.4.2. Product and Application Portfolio

           21.5.4.3. Production Footprint

           21.5.4.4. Sales Footprint

           21.5.4.5. Channel Footprint

           21.5.4.6. Strategy

                21.5.4.6.1. Marketing Strategy

                21.5.4.6.2. Product Strategy

                21.5.4.6.3. Channel Strategy

        21.5.5. RapiGEN Inc.

            21.5.5.1. Overview

            21.5.5.2. Product and Application Portfolio

            21.5.5.3. Production Footprint

            21.5.5.4. Sales Footprint

            21.5.5.5. Channel Footprint

            21.5.5.6. Strategy

                21.5.5.6.1. Marketing Strategy

                21.5.5.6.2. Product Strategy

                21.5.5.6.3. Channel Strategy

        21.5.6. GenBody Inc.

            21.5.6.1. Overview

            21.5.6.2. Product and Application Portfolio

            21.5.6.3. Production Footprint

            21.5.6.4. Sales Footprint

            21.5.6.5. Channel Footprint

            21.5.6.6. Strategy

                21.5.6.6.1. Marketing Strategy

                21.5.6.6.2. Product Strategy

                21.5.6.6.3. Channel Strategy

        21.5.7. JAJ International, Inc.

            21.5.7.1. Overview

            21.5.7.2. Product and Application Portfolio

            21.5.7.3. Production Footprint

            21.5.7.4. Sales Footprint

            21.5.7.5. Channel Footprint

            21.5.7.6. Strategy

                21.5.7.6.1. Marketing Strategy

                21.5.7.6.2. Product Strategy

                21.5.7.6.3. Channel Strategy

        21.5.8. LumiQuick Diagnostics, Inc.

            21.5.8.1. Overview

            21.5.8.2. Product and Application Portfolio

            21.5.8.3. Production Footprint

            21.5.8.4. Sales Footprint

            21.5.8.5. Channel Footprint

            21.5.8.6. Strategy

                21.5.8.6.1. Marketing Strategy

                21.5.8.6.2. Product Strategy

                21.5.8.6.3. Channel Strategy

        21.5.9. Biocan Diagnostics Inc.

            21.5.9.1. Overview

            21.5.9.2. Product and Application Portfolio

            21.5.9.3. Production Footprint

            21.5.9.4. Sales Footprint

            21.5.9.5. Channel Footprint

            21.5.9.6. Strategy

                21.5.9.6.1. Marketing Strategy

                21.5.9.6.2. Product Strategy

                21.5.9.6.3. Channel Strategy

        21.5.10. NECTAR LIFESCIENCES LTD.

            21.5.10.1. Overview

            21.5.10.2. Product and Application Portfolio

            21.5.10.3. Production Footprint

            21.5.10.4. Sales Footprint

            21.5.10.5. Channel Footprint

            21.5.10.6. Strategy

                21.5.10.6.1. Marketing Strategy

                21.5.10.6.2. Product Strategy

                21.5.10.6.3. Channel Strategy

22. Assumptions and Acronyms Used

22.1. A glossary of assumption and acronyms used in the report

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Zika Virus Testing Market Pricing Analysis (US$) By Region, 2021

Table 02: North America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country

Table 03: North America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 04: North America Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 05: North America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 06: Latin America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country

Table 07: Latin America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 08: Latin America Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 09: Latin America Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 10: Europe Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country

Table 11: Europe Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 12: Europe Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 13: Europe Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 14: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country

Table 15: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 16: Central America Cluster Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 17: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 18: South-East Asia Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country

Table 19: South-East Asia Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 20: South-East Asia Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 21: South-East Asia Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 22: Caribbean Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 23: Caribbean Cluster Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 24: Caribbean Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 25: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Country

Table 26: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By Test Type

Table 27: Central America Cluster Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 28: Central America Cluster Zika Virus Testing Market Size (US$ Mn) Analysis 2016-2020 And Forecast 2021-2031, By End User

Table 29: Global Zika Virus Testing Market Size (US$ Mn) 2016-2020 And Forecast 2021-2031 By Region 

Table 30: Global Zika Virus Testing Market Size (US$ Mn) 2016-2020 And Forecast 2021-2031 By Test Type

Table 31: Global Zika Virus Testing Market Volume (Units) Analysis-2016-2020 And Forecast 2021-2031, By Test Type

Table 32: Global Zika Virus Testing Market Size (US$ Mn) 2016-2020 And Forecast 2021-2031 By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Zika Virus Testing Market Revenue Share By Test Type 2021E & 2031F

Figure 02: Zika Virus Testing Market Revenue Share By End User, 2021E & 2031F

Figure 03: Zika Virus Testing Market Revenue Share By Region, 2021E & 2031F

Figure 04: Global Zika Virus Testing Market Absolute $ Opportunity (US$ Mn), 2020 – 2031

Figure 05: Zika Virus Testing Market, Price (US$) Difference (U.S Vs. Caribbean Cluster), 2016

Figure 06: Global Zika Virus Testing Market Brush Motors, Price Difference (US$) By Region, 2021

Figure 07: Global Zika Virus Testing Market Brush Motors, Price Difference (US$) By Region, 2031

Figure 08: Global Zika Virus Testing Market Brushless Motors, Price Difference (US$) By Region, 2021

Figure 09: Global Zika Virus Testing Market Brushless Motors, Price Difference (US$) By Region, 2031

Figure 10: North America Zika Virus Testing Market Value Share (2021E)

Figure 11: North America Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031

Figure 12: North America Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020

Figure 13: North America Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 14: U.S. Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 15: U.S. Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 16: Canada Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 17: Canada Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 18: North America Brush Motors Market Size (US$ Mn) Analysis, 2016-2020

Figure 19: North America Brush Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 20: North America Brushless Motors Market Size (US$ Mn) Analysis, 2016-2020

Figure 21: North America Brushless Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 22: North America Dental Clinics Market Size (US$ Mn) Analysis, 2016-2020

Figure 23: North America Dental Clinics Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 24: North America Hospitals Market Size (US$ Mn) Analysis, 2016-2020

Figure 25: North America Hospitals Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 26: North America Others Market Size (US$ Mn) Analysis, 2016-2020

Figure 27: North America Others Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 28: North America Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031

Figure 29: North America Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031

Figure 30: North America Zika Virus Testing Market Attractiveness Analysis By Country, 2021-2031

Figure 31: Latin America Zika Virus Testing Market Value Share (2021E)

Figure 32: Latin America Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031

Figure 33: Latin America Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020

Figure 34: Latin America Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 35: Brazil Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 36: Brazil Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 37: Mexico Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 38: Mexico Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 39: Rest Of Latin America Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 40: Rest Of Latin America Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 41: Latin America Brush Motors Market Size (US$ Mn) Analysis, 2016-2020

Figure 42: Latin America Brush Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 43: Latin America Brushless Motors Market Size (US$ Mn) Analysis, 2016-2020

Figure 44: Latin America Brushless Motors Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 45: Latin America Dental Clinics Market Size (US$ Mn) Analysis, 2016-2020

Figure 46: Latin America Dental Clinics Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 47: Latin America Hospitals Market Size (US$ Mn) Analysis, 2016-2020

Figure 48: Latin America Hospitals Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 49: Latin America Others Market Size (US$ Mn) Analysis, 2016-2020

Figure 50: Latin America Others Market Value (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 51: Latin America Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031

Figure 52: Latin America Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031

Figure 53: Latin America Zika Virus Testing Market Attractiveness Analysis By Country, 2021-2031

Figure 54: Europe Zika Virus Testing Market Value Share (2021E)

Figure 55: Europe Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031

Figure 56: Europe Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020

Figure 57: Europe Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 58: U.K. Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 59: U.K. Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 60: Germany Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 61: Germany Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 62: France Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 63: France Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 64: Italy Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 65: Italy Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 66: Spain Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 67: Spain Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 68: Nordic Countries Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 69: Nordic Countries Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 70: Central America Cluster Zika Virus Testing Market Value Share (2021E)

Figure 71: Central America Cluster Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031

Figure 72: Central America Cluster Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020

Figure 73: Central America Cluster Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 74: Costa Rica Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 75: Costa Rica Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 76: Nicaragua Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 77: Nicaragua Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 78: Rest Of Central America Cluster Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 79: Rest Of Central America Cluster Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 80: Central America Cluster Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031

Figure 81: Central America Cluster Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031

Figure 82: South-East Asia Zika Virus Testing Market Value Share (2021E)

Figure 83: South-East Asia Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031

Figure 84: South-East Asia Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020

Figure 85: South-East Asia Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 86: Singapore Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 87: Singapore Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 88: Thailand Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 89: Thailand Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 90: Vietnam Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 91: Vietnam Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 92: Rest Of South-East Asia Zika Virus Testing Historical Market Size (US$ Mn), 2016-2020

Figure 93: Caribbean Cluster Zika Virus Testing Market Value Share Analysis (%) By End User, 2021 & 2031

Figure 94: Caribbean Cluster Zika Virus Testing Historical Market Size (US$ Mn) Analysis, 2016-2020

Figure 95: Caribbean Cluster Zika Virus Testing Market Size (US$ Mn) & Y-O-Y Growth (%), 2021-2031

Figure 96: Central America Cluster Zika Virus Testing Market Value Share (2021E)

Figure 97: Central America Cluster Zika Virus Testing Market Value Share Analysis (%) By Country, 2021 & 2031

Figure 98: Global Zika Virus Testing Market Share Analysis (%) By Region, 2021 & 2031

Figure 99: Global Zika Virus Testing Market Y-O-Y Growth (%) 2021-2031, By Region

Figure 100: Global Zika Virus Testing Market Share Analysis (%) By Test Type, 2021 & 2031

Figure 101: Global Zika Virus Testing Market Y-O-Y Growth (%) 2021-2031, By Test Type

Figure 102: Global Zika Virus Testing Market Attractiveness Analysis By Test Type, 2021-2031

Figure 103: Global Zika Virus Testing Market Share Analysis (%) By End User, 2021 & 2031

Figure 104: Global Zika Virus Testing Market Y-O-Y Growth (%) 2021-2031, By End User

Figure 105: Global Zika Virus Testing Market Attractiveness Analysis By End User, 2021-2031

Figure 106: Global Zika Virus Testing Market Value Analysis And Forecast, 2016–2031 (US$ Mn)

Figure 107: Global Zika Virus Testing Market Absolute $ Opportunity (US$ Mn), 2016-2020

Figure 108: Global Zika Virus Testing Market Absolute $ Opportunity (US$ Mn), 2016–2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Automated Cannabis Testing Market

Published : March 2019

Healthcare

Specific Protein Testing Market

Published : October 2017

Healthcare

Vestibular Testing System Market

Published : September 2017

Healthcare

Hemostasis Testing Systems Market

Published : March 2016

Google translate

Zika Virus Testing Market